Published in Clin Chem on February 01, 2002
Non-invasive markers for hepatic fibrosis. BMC Gastroenterol (2011) 1.65
Serum arylesterase and paraoxonase activity in patients with chronic hepatitis. World J Gastroenterol (2005) 1.00
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol (2009) 0.99
Monounsaturated fat decreases hepatic lipid content in non-alcoholic fatty liver disease in rats. World J Gastroenterol (2007) 0.94
Measurement of serum paraoxonase-1 activity in the evaluation of liver function. World J Gastroenterol (2009) 0.91
Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved. Mol Med (2007) 0.87
The role of 'paraoxonase-1 activity' as an antioxidant in coronary artery diseases. J Clin Diagn Res (2013) 0.86
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment. Lipids Health Dis (2010) 0.83
Paraoxonase-1 status in patients with hereditary hemochromatosis. J Lipid Res (2013) 0.82
Correlation of serum arylesterase activity on phenylacetate estimated by the integrated method to common classical biochemical indexes of liver damage. J Zhejiang Univ Sci B (2007) 0.82
Serum paraoxonase 1 activity status in patients with liver disorders. Saudi J Gastroenterol (2010) 0.82
Measurement of serum PON-3 concentration: method evaluation, reference values, and influence of genotypes in a population-based study. J Lipid Res (2011) 0.80
Effect of PON1 gene polymorphisms in Turkish patients with hepatocellular carcinoma. Meta Gene (2013) 0.80
Effects of amlodipine, captopril, and bezafibrate on oxidative milieu in rats with fatty liver. Dig Dis Sci (2007) 0.78
The level of DING proteins is increased in HIV-infected patients: in vitro and in vivo studies. PLoS One (2012) 0.78
Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease. Int J Hepatol (2012) 0.77
Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows. BMC Vet Res (2013) 0.76
Açai (Euterpe oleracea Mart.) Upregulates Paraoxonase 1 Gene Expression and Activity with Concomitant Reduction of Hepatic Steatosis in High-Fat Diet-Fed Rats. Oxid Med Cell Longev (2016) 0.76
Time-dependent modulation of rat serum paraoxonase 1 activity by fasting. Pflugers Arch (2006) 0.76
Serum Basal Paraoxonase 1 Activity as an Additional Liver Function Test for the Evaluation of Patients with Chronic Hepatitis. J Clin Diagn Res (2015) 0.75
Effects of vitamin A, C and E, or omega-3 fatty acid supplementation on the level of paraoxonase and arylesterase activity in streptozotocin-induced diabetic rats: an investigation of activities in plasma, and heart and liver homogenates. Singapore Med J (2016) 0.75
Chemokine ligand 2 and paraoxonase-1 in non-alcoholic fatty liver disease: The search for alternative causative factors. World J Gastroenterol (2015) 0.75
AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell (2009) 2.75
Protection against fatty liver but normal adipogenesis in mice lacking adipose differentiation-related protein. Mol Cell Biol (2006) 2.63
Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem (2002) 2.33
Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation (2009) 2.19
Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell (2009) 2.00
Metformin: multi-faceted protection against cancer. Oncotarget (2011) 2.00
Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients. J Am Coll Cardiol (2006) 1.99
Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. Free Radic Biol Med (2008) 1.86
A consensus view of protein dynamics. Proc Natl Acad Sci U S A (2007) 1.73
New variants in the mitochondrial genomes of schizophrenic patients. Eur J Hum Genet (2006) 1.72
The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa. Clin Cancer Res (2012) 1.61
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis. Cell Cycle (2010) 1.60
The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci (2009) 1.57
Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology (2010) 1.56
Plasma homocysteine concentrations in patients with liver cirrhosis. Clin Chem (2002) 1.50
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas. Genes Chromosomes Cancer (2010) 1.50
Dilated aortic root is related to a global aortic dilating diathesis. J Vasc Surg (2010) 1.48
Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility. Arthritis Rheum (2008) 1.46
Comparative genomic hybridization analysis reveals new different subgroups in early-stage bladder tumors. Urology (2009) 1.44
LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis (2013) 1.41
Heterozygous apolipoprotein (a) status and protein expression as a risk factor for premature coronary heart disease. J Lab Clin Med (2002) 1.40
Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle (2012) 1.39
[Clinical applications of erythropoietin: Impact on blood transfusion]. Med Clin (Barc) (2002) 1.39
Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation (2004) 1.37
Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice. J Lipid Res (2005) 1.35
Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) (2012) 1.31
Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genet (2009) 1.24
The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells. Cell Cycle (2013) 1.20
Feeding apolipoprotein E-knockout mice with cholesterol and fat enriched diets may be a model of non-alcoholic steatohepatitis. Mol Cell Biochem (2005) 1.19
Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial. Ann Intern Med (2005) 1.19
CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile. J Immunol (2014) 1.18
Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem (2003) 1.16
Metabolomic assessment of the effect of dietary cholesterol in the progressive development of fatty liver disease. J Proteome Res (2010) 1.15
Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment. Am J Med Genet B Neuropsychiatr Genet (2009) 1.14
The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. Sci Rep (2013) 1.14
MoDEL (Molecular Dynamics Extended Library): a database of atomistic molecular dynamics trajectories. Structure (2010) 1.12
Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem (2002) 1.11
Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm (2010) 1.09
Gerosuppressant metformin: less is more. Aging (Albany NY) (2011) 1.08
Treat-to-target low-density lipoprotein cholesterol: time to debate a too simple and dogmatic paradigm. Angiology (2013) 1.07
Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life (2010) 1.06
Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res (2012) 1.05
The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells. Cell Cycle (2012) 1.04
Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol (2009) 1.03
Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun (2005) 1.02
Rosiglitazone and fenofibrate exacerbate liver steatosis in a mouse model of obesity and hyperlipidemia. A transcriptomic and metabolomic study. J Proteome Res (2014) 1.01
The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem (2008) 1.01
Metformin and the ATM DNA damage response (DDR): accelerating the onset of stress-induced senescence to boost protection against cancer. Aging (Albany NY) (2011) 1.01
Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. Toxicol Lett (2007) 1.01
The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke (2007) 1.01
Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin. Oncotarget (2013) 1.01
Hepatic monocyte chemoattractant protein-1 is upregulated by dietary cholesterol and contributes to liver steatosis. Cytokine (2009) 1.01
Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle (2013) 1.00
Molecular patterns in the evolution of serrated lesion of the colorectum. Int J Cancer (2012) 1.00
Diet and lifestyle are associated with serum C-reactive protein concentrations in a population-based study. J Lab Clin Med (2005) 0.99
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. BMC Gastroenterol (2009) 0.99
Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes Chromosomes Cancer (2010) 0.98
Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta (2007) 0.98
Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle. J Clin Invest (2015) 0.98
The consequences of chromosomal aneuploidy on the transcriptome of cancer cells. Biochim Biophys Acta (2012) 0.97
Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice. Endocrinology (2009) 0.97
Immunohistochemical analysis of paraoxonases-1 and 3 in human atheromatous plaques. Eur J Clin Invest (2010) 0.96
Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis (2006) 0.96
The influence of HIV infection on the correlation between plasma concentrations of monocyte chemoattractant protein-1 and carotid atherosclerosis. Clin Chim Acta (2006) 0.96
Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols. Am J Physiol Gastrointest Liver Physiol (2009) 0.96
The efavirenz-induced increase in HDL-cholesterol is influenced by the multidrug resistance gene 1 C3435T polymorphism. AIDS (2005) 0.95
A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets. Int J Cancer (2011) 0.95
An association between plasma ferritin concentrations measured 48 h after delivery and postpartum depression. J Affect Disord (2010) 0.94
The results in rodent models of atherosclerosis are not interchangeable: the influence of diet and strain. Atherosclerosis (2007) 0.94
Paraoxonase-1 is associated with oxidative stress, fibrosis and FAS expression in chronic liver diseases. J Hepatol (2006) 0.94
Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine (2012) 0.94
HIV-infected patients with lipodystrophy have higher rates of carotid atherosclerosis: the role of monocyte chemoattractant protein-1. Cytokine (2006) 0.94
Mitochondrial dysfunction: a basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediators Inflamm (2013) 0.93
Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients. J Infect Dis (2010) 0.93